Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview

10592studies shown

Showing 109-120 of 10,592

Drug study icon

RecruitingNCT06951711

KarXT for manic episodes in bipolarity type I

This study is recruiting in the United States, in Croatia, in India, .... It is testing KarXT for manic episodes in bipolarity type I.

In United States

BipolarityDrugFrom 18 Years to 65 Years

Countries: United States, Croatia, India, ...
Sponsor: Bristol-Myers Squibb
Condition: Bipolarity

Drug study icon

RecruitingNCT07288567

KarXT for schizophrenia

This study is recruiting in the United States, in Argentina, in Colombia, .... It is testing KarXT for schizophrenia.

In United States

SchizophreniaDrugFrom 13 Years to 17 Years

Countries: United States, Argentina, Colombia, ...
Sponsor: Bristol-Myers Squibb
Condition: Schizophrenia

Drug study icon

RecruitingNCT07065240

SPT-300 (GlyphAllo) for depression

This study is recruiting in the United States, in Bulgaria, in Czechia, .... It is testing SPT-300 (GlyphAllo) for depression.

In United States

DepressionDrugFrom 18 Years to 65 Years

Countries: United States, Bulgaria, Czechia, ...
Sponsor: Seaport Therapeutics
Condition: Depression

Drug study icon

RecruitingNCT06223880

Efficacy of AXS-05 Compared to Bupropion in Preventing the Relapse of Depressive Symptoms

This study is recruiting in the United States. It is testing Efficacy of AXS-05 Compared to Bupropion for depression.

In United States

DepressionDrugFrom 18 Years to 65 Years

Countries: United States
Sponsor: Axsome Therapeutics, Inc.
Condition: Depression

Drug study icon

RecruitingNCT07424404

KarXT and KarX-EC for schizophrenia

This study is recruiting in the United States, in France, in Canada, .... It is testing KarXT and KarX-EC for schizophrenia.

In United States

SchizophreniaDrugFrom 5 Years to 17 Years

Countries: United States, France, Canada, ...
Sponsor: Karuna Therapeutics, Inc., a Bristol Myers Squibb company
Condition: Schizophrenia

Drug study icon

RecruitingNCT07196501

Maintenance Effect of NBI-1065845 for depression

This study is recruiting in the United States, in Australia, in Canada, .... It is testing Maintenance Effect of NBI-1065845 for depression.

In United States

DepressionDrugOver 18 Years

Countries: United States, Australia, Canada, ...
Sponsor: Neurocrine Biosciences
Condition: Depression

Drug study icon

RecruitingNCT07061288

Safety, Tolerability, and PK of an Injectable Form of KarXT

This study is recruiting in the United States. It focuses on Schizophrenia.

In United States

SchizophreniaDrugFrom 18 Years to 55 Years

Countries: United States
Sponsor: Bristol-Myers Squibb
Condition: Schizophrenia

Drug study icon

RecruitingNCT07621237

TNX-102 SL Monotherapy Versus Placebo in people with Major Depressive Disorder (MDD)

This study is recruiting in the United States. It is testing TNX-102 SL Monotherapy for depression.

In United States

DepressionDrugOver 18 Years

Countries: United States
Sponsor: Tonix Pharmaceuticals, Inc.
Condition: Depression

Drug study icon

RecruitingNCT07540338

A Study to Investigate Lithium Brain/Plasma Pharmacokinetics and Safety of an AL001 Oral Capsule Compared to a Marketed Immediate-release Lithium Carbonate Capsule in Subjects With Bipolarity type I

This study is recruiting in the United States. It focuses on Bipolarity.

In United States

BipolarityDrugFrom 18 Years to 65 Years

Countries: United States
Sponsor: Alzamend Neuro, Inc.
Condition: Bipolarity

Drug study icon

RecruitingNCT07047820

A Study to Learn More About How Zuranolone Affects Postpartum Depression Symptoms in Participants Who Took it Within 1 Year After The End of Their Pregnancy

This study is recruiting in the United States. It focuses on depression.

In United States

DepressionDrugOver 18 Years

Countries: United States
Sponsor: Biogen
Condition: Depression

Device study icon

RecruitingNCT07405398

A Study to Train a Machine Learning Algorithm for an Evaluation of the Use of Biometric Data Captured at the Wrist for the Identification of Acute Opioid Use Events and the Quantification of Opioid Withdrawal in Opioid Dependent Individuals

This study is recruiting in the United States. It focuses on Addiction.

In United States

AddictionDeviceOver 22 Years

Countries: United States
Sponsor: OpiAID
Condition: Addiction

Behavioral study icon

RecruitingNCT03803332

Trial Comparing Interpersonal Therapy to Exposure Therapy for PTSD

This study is recruiting in the United States. It is testing trial Comparing Interpersonal Therapy to Exposure Therapy for PTSD.

In United States

PTSDBehavioralFrom 18 Years to 85 Years

Countries: United States
Sponsor: Weill Medical College of Cornell University
Condition: PTSD

Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.